With a Ph.D. in pharmacology and a career spanning more than 40 years, this pharmaceutical sciences expert has built a body of work centered on drug discovery, development, and clinical research. His experience includes leading preclinical and clinical programs, designing and overseeing clinical trials, and contributing to regulatory and scientific documentation. His work has focused heavily on oncology and antiviral therapeutics, including treatments for cancer, HIV, herpes, shingles, and cytomegalovirus, as well as research addressing drug interactions and side effect management.

Drawing on his background, he has held senior scientific and executive roles in both pharmaceutical and biotechnology settings, where he directed research initiatives, coordinated cross-functional development efforts, and supported strategic decision-making for therapeutic programs. He also maintains ongoing consulting work, where he advises pharmaceutical companies, clinical trial organizations, and legal teams on drug development processes, patent-related matters, and scientific evaluation of therapeutic agents.

In addition to his scientific contributions, he has more than 10 years of experience as an expert witness, providing analysis and testimony in matters involving pharmaceutical development and intellectual property. His work in this area reflects his involvement in patent development, clinical research, and evaluation of drug efficacy and mechanisms, supported by a substantial record of peer-reviewed publications and patented innovations.